Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 1036 AL 1050

Research advances on L-DOPA-induced dyskinesia: from animal models to human disease

Chen X, Wang Y, Wu H, Cheng C, Le W.

Neurol Sci. 2020 Aug;41(8):2055-2065. doi: 10.1007/s10072-020-04333-5. Epub 2020 Mar 17.

Inheritance of mitochondrial DNA in humans: implications for rare and common diseases

Wei W, Chinnery PF.

J Intern Med. 2020 Jun;287(6):634-644. doi: 10.1111/joim.13047. Epub 2020 Mar 18.

Upregulation of Neuronal Rheb(S16H) for Hippocampal Protection in the Adult Brain

Moon GJ, Shin M, Kim SR.

Int J Mol Sci. 2020 Mar 16;21(6):2023. doi: 10.3390/ijms21062023.

SUMOylation in development and neurodegeneration

Yau TY, Molina O, Courey AJ.

Development. 2020 Mar 18;147(6):dev175703. doi: 10.1242/dev.175703.

[Care of patients with Parkinson's disease in Germany]

Stangl S, Haas K, Eggers C, Reese JP, Tönges L, Volkmann J.

Nervenarzt. 2020 Jun;91(6):493-502. doi: 10.1007/s00115-020-00890-4.

2020 New Drug Update

Hussar DA, Finn LA.

Sr Care Pharm. 2020 Apr 1;35(4):151-161. doi: 10.4140/TCP.n.2020.151.

Nocturia and Nocturnal Polyuria in Neurological Patients: From Epidemiology to Treatment. A Systematic Review of the Literature

Haddad R, Denys P, Arlandis S, Giannantoni A, Del Popolo G, Panicker JN, De Ridder D, Pauwaert K, Van Kerrebroeck PE, Everaert K.

Eur Urol Focus. 2020 Sep 15;6(5):922-934. doi: 10.1016/j.euf.2020.02.007. Epub 2020 Mar 17.

PRKN-related familial Parkinson's disease: First molecular confirmation from East Africa

Dekker MCJ, Suleiman JM, Bhwana D, Howlett WP, Rashid SM, van Minkelen R, Hamel BC.

Parkinsonism Relat Disord. 2020 Apr;73:14-15. doi: 10.1016/j.parkreldis.2020.02.014. Epub 2020 Feb 29.

The genetic architecture of the human cerebral cortex

Grasby KL, Jahanshad N, Painter JN, Colodro-Conde L, Bralten J, Hibar DP, Lind PA, Pizzagalli F, Ching CRK, McMahon MAB, Shatokhina N, Zsembik LCP, Thomopoulos SI, Zhu AH, Strike LT, Agartz I, Alhusaini S, Almeida MAA, Alnæs D, Amlien IK, Andersson M, Ard T, Armstrong NJ, Ashley-Koch A, Atkins JR, Bernard M, Brouwer RM, Buimer EEL, Bülow R, Bürger C, Cannon DM, Chakravarty M, Chen Q, Cheung JW, Couvy-Duchesne B, Dale AM, Dalvie S, de Araujo TK, de Zubicaray GI, de Zwarte SMC, den Braber A, Doan NT, Dohm K, Ehrlich S, Engelbrecht HR, Erk S, Fan CC, Fedko IO, Foley SF, Ford JM, Fukunaga M, Garrett ME, Ge T, Giddaluru S, Goldman AL, Green MJ, Groenewold NA, Grotegerd D, Gurholt TP, Gutman BA, Hansell NK, Harris MA, Harrison MB, Haswell CC, Hauser M, Herms S, Heslenfeld DJ, Ho NF, Hoehn D, Hoffmann P, Holleran L, Hoogman M, Hottenga JJ, Ikeda M, Janowitz D, Jansen IE, Jia T, Jockwitz C, Kanai R, Karama S, Kasperaviciute D, Kaufmann T, Kelly S, Kikuchi M, Klein M, Knapp M, Knodt AR, Krämer B, Lam M, Lancaster TM, Lee PH, Lett TA, Lewis LB, Lopes-Cendes I, Luciano M, Macciardi F, Marquand AF, Mathias SR, Melzer TR, Milaneschi Y, et al.

Science. 2020 Mar 20;367(6484):eaay6690. doi: 10.1126/science.aay6690.

Telemedicine for Hyperkinetic Movement Disorders

Srinivasan R, Ben-Pazi H, Dekker M, Cubo E, Bloem B, Moukheiber E, Gonzalez-Santos J, Guttman M.

Tremor Other Hyperkinet Mov (N Y). 2020 Feb 17;10. doi: 10.7916/tohm.v0.698. eCollection 2020.

What are the considerations for anti-hypertensive treatment in patients with Parkinson's disease?

Jost WH.

Expert Opin Pharmacother. 2020 Jul;21(10):1127-1130. doi: 10.1080/14656566.2020.1744565. Epub 2020 Mar 20.

Clinical practice guidelines based on evidence for cognitive-behavioural therapy in Parkinson's disease comorbidities: A literature review

Zečević I.

Clin Psychol Psychother. 2020 Jul;27(4):504-514. doi: 10.1002/cpp.2448. Epub 2020 Apr 2.

A Spanish Consensus on the Use of Safinamide for Parkinson's Disease in Clinical Practice

Pagonabarraga J, Arbelo JM, Grandas F, Luquin MR, Martínez Martín P, Rodríguez-Oroz MC, Valldeoriola F, Kulisevsky J.

Brain Sci. 2020 Mar 18;10(3):176. doi: 10.3390/brainsci10030176.

The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer

Indrieri A, Carrella S, Carotenuto P, Banfi S, Franco B.

Int J Mol Sci. 2020 Mar 18;21(6):2092. doi: 10.3390/ijms21062092.

A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia

Svenningsson P, Odin P, Dizdar N, Johansson A, Grigoriou S, Tsitsi P, Wictorin K, Bergquist F, Nyholm D, Rinne J, Hansson F, Sonesson C, Tedroff J; IRL752 Collaborators.

Mov Disord. 2020 Jun;35(6):1046-1054. doi: 10.1002/mds.28020. Epub 2020 Mar 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias